Table 2.
Genes used in the MLST scheme, including general description and statistical analysis.
| Gene | Fragment length | % G+C | Haplotypes | Number of | Total number | dN/dS | Tajima's D* | Fu and Li's F | InDel |
|---|---|---|---|---|---|---|---|---|---|
| analysis (bp) | Haplotypes | variable sites | of mutations | mutations | |||||
| glp | 480 | 46.5 | 21 | 25 | 25 | 0.0513 | −1.66632¥ | −2.53677¥ | n.a. |
| gyrB | 537 | 44 | 24 | 28 | 28 | 0.0433 | −0.59551§ | −1.28524§ | n.a. |
| metG | 429 | 42.4 | 21 | 20 | 20 | 0.0169 | −1.56838§ | −2.35963¥ | n.a. |
| pntA | 396 | 46.1 | 17 | 20 | 20 | 0.0050 | 0.85313§ | 0.3387§ | n.a. |
| pyrC | 507 | 42.6 | 25 | 40 | 44 | 0.0591 | −0.18696§ | −0.51942§ | n.a. |
| toxR | 372–390* | 42.7 | 29 | 40 | 44 | 0.1064 | 0.49313§ | 0.14047§ | 4 haplotypes, |
| affecting 18 sites |
*
For the statistical analysis, the gaps were excluded.
¥
Statistical significance: Not significant, 0.10> P > 0.05.
§
Statistical significance: Not significant, P > 0.10. n.a. = not applicable.